BOPA 2017 | Cancer diagnosis and survival in the UK
The early diagnosis of cancer is key to survival; however, with the many demands upon the NHS this can be challenging. In this interview, Graeme Betts from the Regional Manager Health Professional Engagement Programme, Cancer Research UK, UK discusses the current landscape of cancer diagnosis and survival. Topical points covered include the survival rates of cancer patients in the UK vs. other developed nations, and the aims of CRUK in terms of cancer diagnosis and survival rates. This video was recorded at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK.
Get great new content delivered to your inboxSign up